Category: Arecor

  • Arecor heads for London Stock Exchange with drug reformulation strategy

    Arecor Therapeutics is planning to float on the London stock market, to raise funding and awareness for its developmental portfolio of biologic drugs, which are based on already-marketed drugs reformulated to provide extra benefits for patients.  Arecor Therapeutics is the latest company aiming to take advantage of the “feelgood” factor in the biotech sector, which […]